NCT00446836View on ClinicalTrials.gov

Efficacy and Safety Study of Xyotax to Treat Prostate Cancer

PHASE2CompletedINTERVENTIONAL

Enrollment

29

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

November 30, 2007

Study Completion Date

January 31, 2008

Conditions

Prostatic Neoplasms

Interventions

DRUG

Paclitaxel polyglumex (Xyotax)

biologically enhanced chemotherapeutic

Trial Locations (1)

77030

Baylor College of Medicine -Methodist Hospital, Houston

Sponsors

Collaborators (1)

Cellular Therapeutics

All Listed Sponsors

collaborator

Cellular Therapeutics

UNKNOWN

lead

The Methodist Hospital Research Institute

OTHER

NCT00446836 - Efficacy and Safety Study of Xyotax to Treat Prostate Cancer | Biotech Hunter | Biotech Hunter